Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer ; volume:21 ; number:1 ; day:10 ; month:2 ; year:2023 ; pages:1-22 ; date:12.2023
Journal of translational medicine ; 21, Heft 1 (10.2.2023), 1-22, 12.2023
- Urheber
-
Ganji, Mahmoud
Bakhshi, Shohreh
Shoari, Alireza
Ahangari Cohan, Reza
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-023-03955-5
- URN
-
urn:nbn:de:101:1-2023041421052956403052
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ganji, Mahmoud
- Bakhshi, Shohreh
- Shoari, Alireza
- Ahangari Cohan, Reza
- SpringerLink (Online service)
Ähnliche Objekte (12)
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors
Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations
Building shape-focused pharmacophore models for effective docking screening
Combining docking with pharmacophore filtering for improved virtual screening
QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach
3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
Semiempirical MO-methods for QSAR and docking studies
Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies
Quantitative Structure‐activity Relationship (QSAR) Models for Docking Score Correction
Reverse pharmacophore mapping and molecular docking studies for discovery of GTPase HRas as promising drug target for bis-pyrimidine derivatives
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors
Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations
Building shape-focused pharmacophore models for effective docking screening
Combining docking with pharmacophore filtering for improved virtual screening
QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach
3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
Semiempirical MO-methods for QSAR and docking studies
Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies
Quantitative Structure‐activity Relationship (QSAR) Models for Docking Score Correction
Reverse pharmacophore mapping and molecular docking studies for discovery of GTPase HRas as promising drug target for bis-pyrimidine derivatives
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors
Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations
Building shape-focused pharmacophore models for effective docking screening
Combining docking with pharmacophore filtering for improved virtual screening
QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach
3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
Semiempirical MO-methods for QSAR and docking studies
Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies
Quantitative Structure‐activity Relationship (QSAR) Models for Docking Score Correction